DSC studies on the interaction of lipophilic cytarabine prodrugs with DMPC multilamellar vesicles

Cytarabine (1-β- d -arabinofuranosylcytosine, Ara-C), a pyrimidine nucleoside analogue, is used for the treatment of both acute and chronic myeloblastic leukemias and non-Hodgkin lymphoma. It has a very short plasma half-life and a very low oral bioavailability. To overcome these disadvantages, much...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thermal analysis and calorimetry 2019-11, Vol.138 (4), p.2759-2767
Hauptverfasser: Berrio Escobar, Jhon Fernando, Marquez Fernandez, Diana Margarita, Giordani, Cristiano, Castelli, Francesco, Sarpietro, Maria Grazia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2767
container_issue 4
container_start_page 2759
container_title Journal of thermal analysis and calorimetry
container_volume 138
creator Berrio Escobar, Jhon Fernando
Marquez Fernandez, Diana Margarita
Giordani, Cristiano
Castelli, Francesco
Sarpietro, Maria Grazia
description Cytarabine (1-β- d -arabinofuranosylcytosine, Ara-C), a pyrimidine nucleoside analogue, is used for the treatment of both acute and chronic myeloblastic leukemias and non-Hodgkin lymphoma. It has a very short plasma half-life and a very low oral bioavailability. To overcome these disadvantages, much effort has been focused on the design of cytarabine prodrugs. In this study, we have synthesized four different cytarabine prodrugs in order to increase the drug lipophilicity and the affinity of the prodrugs toward the biological membranes, as well as the lipophilic carriers. Differential scanning calorimetry was used to study the interaction of cytarabine and its prodrugs with multilamellar vesicles (MLVs) made of dimyristoylphosphatidylcholine (DMPC) and used as a model of biomembranes as well as a lipophilic carrier. The results showed that the 4- N -acetyl-2′,3′-5′-acetyl derivative and the prodrug with short chain fatty acids do not have a significant affinity with MLVs, whereas the prodrugs with long chain fatty acids have a stronger affinity with the MLVs with respect to cytarabine. The entity of the affinity depends on the fatty acids length. The increased affinity could be due to the fatty acid moieties which allow the molecule to insert among the phospholipid molecules. These results provide information on the interaction of these prodrugs with biomembranes and could be useful to design liposomes as carriers for the prodrugs.
doi_str_mv 10.1007/s10973-019-08780-x
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2316006973</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A606307464</galeid><sourcerecordid>A606307464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-70a59b29ec54c738a582ad0e2557f31c723705d3cef7a7b057b73a33e58f77533</originalsourceid><addsrcrecordid>eNp9kV1PwyAUhhujiXP6B7wi8cqLzkMZpb008zPRaPy4Joyebiy0nUB1-_eiMzFLjOGCA3ke4PAmyTGFEQUQZ55CKVgKtEyhEAWkq51kQHlRpFmZ5buxZrHOKYf95MD7BQCUJdBBoi6eJ8SHvjLoSdeSMEdi2oBO6WDiuquJNctuOTfWaKLXQTk1NS2Spesq1888-TBhTi7uHyek6W0wVjVorXLkHb3RFv1hslcr6_HoZx4mr1eXL5Ob9O7h-nZyfpfqMRchFaB4Oc1K1HysBSsULzJVAWaci5pRLTImgFdMYy2UmAIXU8EUY8iLWgjO2DA52ZwbX_bWow9y0fWujVfKjNEcII8_9EvNlEVp2roLsdXGeC3Pc8gZiHE-jtToDyqOChujuxZrE_e3hNMtITIBV2Gmeu_l7fPTNpttWO067x3WculMo9xaUpBfacpNmjKmKb_TlKsosY3kI9zO0P1294_1CSwDoME</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2316006973</pqid></control><display><type>article</type><title>DSC studies on the interaction of lipophilic cytarabine prodrugs with DMPC multilamellar vesicles</title><source>Springer Nature - Complete Springer Journals</source><creator>Berrio Escobar, Jhon Fernando ; Marquez Fernandez, Diana Margarita ; Giordani, Cristiano ; Castelli, Francesco ; Sarpietro, Maria Grazia</creator><creatorcontrib>Berrio Escobar, Jhon Fernando ; Marquez Fernandez, Diana Margarita ; Giordani, Cristiano ; Castelli, Francesco ; Sarpietro, Maria Grazia</creatorcontrib><description>Cytarabine (1-β- d -arabinofuranosylcytosine, Ara-C), a pyrimidine nucleoside analogue, is used for the treatment of both acute and chronic myeloblastic leukemias and non-Hodgkin lymphoma. It has a very short plasma half-life and a very low oral bioavailability. To overcome these disadvantages, much effort has been focused on the design of cytarabine prodrugs. In this study, we have synthesized four different cytarabine prodrugs in order to increase the drug lipophilicity and the affinity of the prodrugs toward the biological membranes, as well as the lipophilic carriers. Differential scanning calorimetry was used to study the interaction of cytarabine and its prodrugs with multilamellar vesicles (MLVs) made of dimyristoylphosphatidylcholine (DMPC) and used as a model of biomembranes as well as a lipophilic carrier. The results showed that the 4- N -acetyl-2′,3′-5′-acetyl derivative and the prodrug with short chain fatty acids do not have a significant affinity with MLVs, whereas the prodrugs with long chain fatty acids have a stronger affinity with the MLVs with respect to cytarabine. The entity of the affinity depends on the fatty acids length. The increased affinity could be due to the fatty acid moieties which allow the molecule to insert among the phospholipid molecules. These results provide information on the interaction of these prodrugs with biomembranes and could be useful to design liposomes as carriers for the prodrugs.</description><identifier>ISSN: 1388-6150</identifier><identifier>EISSN: 1588-2926</identifier><identifier>DOI: 10.1007/s10973-019-08780-x</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Affinity ; Analysis ; Analytical Chemistry ; Bioavailability ; Calorimetry ; Care and treatment ; Chemical compounds ; Chemistry ; Chemistry and Materials Science ; Cytarabine ; Drugs ; Fatty acids ; Fish oils ; Inorganic Chemistry ; Leukemia ; Lipophilicity ; Liposomes ; Measurement Science and Instrumentation ; Non-Hodgkin's lymphomas ; Phospholipids ; Physical Chemistry ; Polymer Sciences ; Pyrimidines ; Vesicles</subject><ispartof>Journal of thermal analysis and calorimetry, 2019-11, Vol.138 (4), p.2759-2767</ispartof><rights>Akadémiai Kiadó, Budapest, Hungary 2019</rights><rights>COPYRIGHT 2019 Springer</rights><rights>Copyright Springer Nature B.V. 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-70a59b29ec54c738a582ad0e2557f31c723705d3cef7a7b057b73a33e58f77533</citedby><cites>FETCH-LOGICAL-c457t-70a59b29ec54c738a582ad0e2557f31c723705d3cef7a7b057b73a33e58f77533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10973-019-08780-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10973-019-08780-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Berrio Escobar, Jhon Fernando</creatorcontrib><creatorcontrib>Marquez Fernandez, Diana Margarita</creatorcontrib><creatorcontrib>Giordani, Cristiano</creatorcontrib><creatorcontrib>Castelli, Francesco</creatorcontrib><creatorcontrib>Sarpietro, Maria Grazia</creatorcontrib><title>DSC studies on the interaction of lipophilic cytarabine prodrugs with DMPC multilamellar vesicles</title><title>Journal of thermal analysis and calorimetry</title><addtitle>J Therm Anal Calorim</addtitle><description>Cytarabine (1-β- d -arabinofuranosylcytosine, Ara-C), a pyrimidine nucleoside analogue, is used for the treatment of both acute and chronic myeloblastic leukemias and non-Hodgkin lymphoma. It has a very short plasma half-life and a very low oral bioavailability. To overcome these disadvantages, much effort has been focused on the design of cytarabine prodrugs. In this study, we have synthesized four different cytarabine prodrugs in order to increase the drug lipophilicity and the affinity of the prodrugs toward the biological membranes, as well as the lipophilic carriers. Differential scanning calorimetry was used to study the interaction of cytarabine and its prodrugs with multilamellar vesicles (MLVs) made of dimyristoylphosphatidylcholine (DMPC) and used as a model of biomembranes as well as a lipophilic carrier. The results showed that the 4- N -acetyl-2′,3′-5′-acetyl derivative and the prodrug with short chain fatty acids do not have a significant affinity with MLVs, whereas the prodrugs with long chain fatty acids have a stronger affinity with the MLVs with respect to cytarabine. The entity of the affinity depends on the fatty acids length. The increased affinity could be due to the fatty acid moieties which allow the molecule to insert among the phospholipid molecules. These results provide information on the interaction of these prodrugs with biomembranes and could be useful to design liposomes as carriers for the prodrugs.</description><subject>Affinity</subject><subject>Analysis</subject><subject>Analytical Chemistry</subject><subject>Bioavailability</subject><subject>Calorimetry</subject><subject>Care and treatment</subject><subject>Chemical compounds</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Cytarabine</subject><subject>Drugs</subject><subject>Fatty acids</subject><subject>Fish oils</subject><subject>Inorganic Chemistry</subject><subject>Leukemia</subject><subject>Lipophilicity</subject><subject>Liposomes</subject><subject>Measurement Science and Instrumentation</subject><subject>Non-Hodgkin's lymphomas</subject><subject>Phospholipids</subject><subject>Physical Chemistry</subject><subject>Polymer Sciences</subject><subject>Pyrimidines</subject><subject>Vesicles</subject><issn>1388-6150</issn><issn>1588-2926</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kV1PwyAUhhujiXP6B7wi8cqLzkMZpb008zPRaPy4Joyebiy0nUB1-_eiMzFLjOGCA3ke4PAmyTGFEQUQZ55CKVgKtEyhEAWkq51kQHlRpFmZ5buxZrHOKYf95MD7BQCUJdBBoi6eJ8SHvjLoSdeSMEdi2oBO6WDiuquJNctuOTfWaKLXQTk1NS2Spesq1888-TBhTi7uHyek6W0wVjVorXLkHb3RFv1hslcr6_HoZx4mr1eXL5Ob9O7h-nZyfpfqMRchFaB4Oc1K1HysBSsULzJVAWaci5pRLTImgFdMYy2UmAIXU8EUY8iLWgjO2DA52ZwbX_bWow9y0fWujVfKjNEcII8_9EvNlEVp2roLsdXGeC3Pc8gZiHE-jtToDyqOChujuxZrE_e3hNMtITIBV2Gmeu_l7fPTNpttWO067x3WculMo9xaUpBfacpNmjKmKb_TlKsosY3kI9zO0P1294_1CSwDoME</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Berrio Escobar, Jhon Fernando</creator><creator>Marquez Fernandez, Diana Margarita</creator><creator>Giordani, Cristiano</creator><creator>Castelli, Francesco</creator><creator>Sarpietro, Maria Grazia</creator><general>Springer International Publishing</general><general>Springer</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope></search><sort><creationdate>20191101</creationdate><title>DSC studies on the interaction of lipophilic cytarabine prodrugs with DMPC multilamellar vesicles</title><author>Berrio Escobar, Jhon Fernando ; Marquez Fernandez, Diana Margarita ; Giordani, Cristiano ; Castelli, Francesco ; Sarpietro, Maria Grazia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-70a59b29ec54c738a582ad0e2557f31c723705d3cef7a7b057b73a33e58f77533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Affinity</topic><topic>Analysis</topic><topic>Analytical Chemistry</topic><topic>Bioavailability</topic><topic>Calorimetry</topic><topic>Care and treatment</topic><topic>Chemical compounds</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Cytarabine</topic><topic>Drugs</topic><topic>Fatty acids</topic><topic>Fish oils</topic><topic>Inorganic Chemistry</topic><topic>Leukemia</topic><topic>Lipophilicity</topic><topic>Liposomes</topic><topic>Measurement Science and Instrumentation</topic><topic>Non-Hodgkin's lymphomas</topic><topic>Phospholipids</topic><topic>Physical Chemistry</topic><topic>Polymer Sciences</topic><topic>Pyrimidines</topic><topic>Vesicles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berrio Escobar, Jhon Fernando</creatorcontrib><creatorcontrib>Marquez Fernandez, Diana Margarita</creatorcontrib><creatorcontrib>Giordani, Cristiano</creatorcontrib><creatorcontrib>Castelli, Francesco</creatorcontrib><creatorcontrib>Sarpietro, Maria Grazia</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Science</collection><jtitle>Journal of thermal analysis and calorimetry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berrio Escobar, Jhon Fernando</au><au>Marquez Fernandez, Diana Margarita</au><au>Giordani, Cristiano</au><au>Castelli, Francesco</au><au>Sarpietro, Maria Grazia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DSC studies on the interaction of lipophilic cytarabine prodrugs with DMPC multilamellar vesicles</atitle><jtitle>Journal of thermal analysis and calorimetry</jtitle><stitle>J Therm Anal Calorim</stitle><date>2019-11-01</date><risdate>2019</risdate><volume>138</volume><issue>4</issue><spage>2759</spage><epage>2767</epage><pages>2759-2767</pages><issn>1388-6150</issn><eissn>1588-2926</eissn><abstract>Cytarabine (1-β- d -arabinofuranosylcytosine, Ara-C), a pyrimidine nucleoside analogue, is used for the treatment of both acute and chronic myeloblastic leukemias and non-Hodgkin lymphoma. It has a very short plasma half-life and a very low oral bioavailability. To overcome these disadvantages, much effort has been focused on the design of cytarabine prodrugs. In this study, we have synthesized four different cytarabine prodrugs in order to increase the drug lipophilicity and the affinity of the prodrugs toward the biological membranes, as well as the lipophilic carriers. Differential scanning calorimetry was used to study the interaction of cytarabine and its prodrugs with multilamellar vesicles (MLVs) made of dimyristoylphosphatidylcholine (DMPC) and used as a model of biomembranes as well as a lipophilic carrier. The results showed that the 4- N -acetyl-2′,3′-5′-acetyl derivative and the prodrug with short chain fatty acids do not have a significant affinity with MLVs, whereas the prodrugs with long chain fatty acids have a stronger affinity with the MLVs with respect to cytarabine. The entity of the affinity depends on the fatty acids length. The increased affinity could be due to the fatty acid moieties which allow the molecule to insert among the phospholipid molecules. These results provide information on the interaction of these prodrugs with biomembranes and could be useful to design liposomes as carriers for the prodrugs.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><doi>10.1007/s10973-019-08780-x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1388-6150
ispartof Journal of thermal analysis and calorimetry, 2019-11, Vol.138 (4), p.2759-2767
issn 1388-6150
1588-2926
language eng
recordid cdi_proquest_journals_2316006973
source Springer Nature - Complete Springer Journals
subjects Affinity
Analysis
Analytical Chemistry
Bioavailability
Calorimetry
Care and treatment
Chemical compounds
Chemistry
Chemistry and Materials Science
Cytarabine
Drugs
Fatty acids
Fish oils
Inorganic Chemistry
Leukemia
Lipophilicity
Liposomes
Measurement Science and Instrumentation
Non-Hodgkin's lymphomas
Phospholipids
Physical Chemistry
Polymer Sciences
Pyrimidines
Vesicles
title DSC studies on the interaction of lipophilic cytarabine prodrugs with DMPC multilamellar vesicles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T22%3A42%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DSC%20studies%20on%20the%20interaction%20of%20lipophilic%20cytarabine%20prodrugs%20with%20DMPC%20multilamellar%20vesicles&rft.jtitle=Journal%20of%20thermal%20analysis%20and%20calorimetry&rft.au=Berrio%20Escobar,%20Jhon%20Fernando&rft.date=2019-11-01&rft.volume=138&rft.issue=4&rft.spage=2759&rft.epage=2767&rft.pages=2759-2767&rft.issn=1388-6150&rft.eissn=1588-2926&rft_id=info:doi/10.1007/s10973-019-08780-x&rft_dat=%3Cgale_proqu%3EA606307464%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2316006973&rft_id=info:pmid/&rft_galeid=A606307464&rfr_iscdi=true